GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NaviFUS Corp (ROCO:6872) » Definitions » Total Operating Expense

NaviFUS (ROCO:6872) Total Operating Expense : NT$133.52 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is NaviFUS Total Operating Expense?

NaviFUS's Total Operating Expense for the three months ended in Mar. 2025 was NT$36.65 Mil. NaviFUS's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was NT$133.52 Mil.


NaviFUS Total Operating Expense Historical Data

The historical data trend for NaviFUS's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NaviFUS Total Operating Expense Chart

NaviFUS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial 64.91 82.58 89.39 88.25 120.56

NaviFUS Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.70 32.04 36.81 28.02 36.65

NaviFUS Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$133.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NaviFUS Total Operating Expense Related Terms

Thank you for viewing the detailed overview of NaviFUS's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


NaviFUS Business Description

Traded in Other Exchanges
N/A
Address
No. 508, Section 7 , Zhongxiao East Road, 16th Floor, Nangang District, Taipei City, TWN, 103
NaviFUS Corp is a Biotech company providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. Its product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for treatment outcomes. Its vision is to cater to CNS disease patients locally and globally by bringing therapeutic ultrasound technology to clinical use.

NaviFUS Headlines

No Headlines